Epicutaneous Immunization with Type II Collagen Inhibits Arthritis
Author Information
Author(s): Strid Jessica, Tan Lee Aun, Strobel Stephan, Londei Marco, Callard Robin
Primary Institution: Institute of Child Health, University College London
Hypothesis
Can epicutaneous immunization with type II collagen modify the autoimmune inflammatory response in chronic collagen-induced arthritis?
Conclusion
Epicutaneous immunization with type II collagen significantly inhibits the development and progression of chronic collagen-induced arthritis.
Supporting Evidence
- Epicutaneous immunization significantly reduced disease severity and delayed onset in treated mice.
- Treated mice showed lower levels of pathogenic Th1 responses and higher Th2 responses.
- Histological analysis revealed less joint damage in treated mice compared to controls.
Takeaway
Putting a special protein on the skin can help stop a painful joint disease in mice.
Methodology
DBA/1-TCR-β Tg mice were epicutaneously immunized with type II collagen before and after the induction of arthritis, and various immune responses were measured.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
DBA/1-TCR-β Tg mice, male, aged 6-8 weeks.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website